Drug interactions

References

• Ahrens, F., Gabel, G., Gartz, B., Aschenbach, J.R. (2002). Release and permeation of histamine are affected by diamine oxydase in the pig large intestine. Inflamm Res 51(Suppl):S83–S84.
   PubMedGoogle Scholar
• Anderson, M.C., Hasan, F., McCrodden, J.M., Tipton, K.F. (1993). Monoamine oxidase inhibitors and the cheese effect. Neurochem Res 18:1145–1149.
   PubMed Web of Science ®Google Scholar
• Andrés, N., Lizcano, J.M., Rodríguez, M.J., Romera, M., Unzeta, M., Mahy, N. (2001). Tissue activity and cellular localization of human semicarbazide-sensitive amine oxidase. J Histochem Cytochem 49:209–217.
   PubMed Web of Science ®Google Scholar
• Arimoto, R. (2006). Computational models for predicting interactions with cytochrome P450 enzyme. Curr Top Med Chem 6:1609–1618.
   PubMed Web of Science ®Google Scholar
• Arinç, E., Arslan, S., Bozcaarmutlu, A., Adali, O. (2007). Effects of diabetes on rabbit kidney and lung CYP2E1 and CYP2B4 expression and drug metabolism and potentiation ofcarcinogenic activity of N-nitrosodimethylamine in kidney and lung. Food Chem Toxicol 45:107–111.
   PubMed Web of Science ®Google Scholar
• Averill-Bates, D.A., Agostinelli, E., Przybytkowski, E., Mondovi, B. (1994). Aldehyde dehydrogenase and cytotoxicity of purified bovine serum amine oxidase and spermine in Chinese hamster ovary cells. Biochem Cell Biol 72:36–42.
   PubMed Web of Science ®Google Scholar
• Averill-Bates, D.A., Ke, Q., Tanel, A., Roy, J., Fortier, G., Agostinelli, E. (2008). Mechanism of cell death induced by spermine and amine oxidase in mouse melanoma cells. Int J Oncol 32:79–88.
   PubMed Web of Science ®Google Scholar
• Bachmann, K., White, D., Jauregui, L., Schwartz, J.I., Agrawal, N.G., Mazenko, R., et al. (2003). An evaluation of the dose- dependent inhibition of CYP1A2 by rofecoxib using theophylline as a CYP1A2 probe. J Clin Pharmacol 43:1082–1090.
   PubMed Web of Science ®Google Scholar
• Bachmann, K.A. (2006). Inhibition constants, inhibitor concentrations, and the prediction of inhibitory drug drug interactions: pitfalls, progress, and promise. Curr Drug Metab 7:1–14.
   PubMed Web of Science ®Google Scholar
• Bailey, D.G., Arnold, J.M.O., Munoz, C., Spence, J.D. (1993). Grapefruit juice-felodipine interaction: mechanism, predictability, and effect of naringin. Clin Pharmacol Ther 53:637–642.
   PubMed Web of Science ®Google Scholar
• Bailey, D.G., Dresser, G.K., Kreeft, J.H., Munoz, C., Freeman, D.J., Bend, J.R. (2000). Grapefruit-felodipine interaction: effect of unprocessed fruit and probable active ingredients. Clin Pharmacol Ther 68:468–477.
   PubMed Web of Science ®Google Scholar
• Bailey, D.G., Dresser, G.K., Leake, B.F., Kim, R.B. (2007). Naringin is a major and selective clinical inhibitor of organic anion-transporting polypeptide 1A2 (OATP1A2) in grapefruit juice. Clin Pharmacol Ther 81:495–502.
   PubMed Web of Science ®Google Scholar
• Bain, M.A., Fornasini, G., Evans, A.M. (2005). Trimethylamine: metabolic, pharmacokinetic, and safety aspects. Curr Drug Metab 6:227–240.
   PubMed Web of Science ®Google Scholar
• Banfield, C. (2001). Lack of drug interactions between desloratadine and other common medications. Allergy 56(Suppl 68): 200 (No. 636).
   Google Scholar
• Banfield, C., Gupta, S., Marino, M., Lim, J., Affrime, M. (2002a). Grapefruit juice reduces the oral bioavailability of fexofenadine but not desloratadine. Clin Pharmacokinet 41:311–318.
   PubMed Web of Science ®Google Scholar
• Banfield, C., Herron, J., Keung, A., Padhi, D., Affrime, M. (2002b). Desloratadine has no clinically relevant electrocardiographic or pharmacodynamic interactions with ketoconazole. Clin Pharmacokinet 41(Suppl 1):37–44.
   PubMedGoogle Scholar
• Barbanoj, M.J., Garcia-Gea, C., Antonijoan, R., Izquierdo, I., Donado, E., Pérez, I., Solans, A., et al. (2006). Evaluation of the cognitive, psychomotor and pharmacokinetic profiles of rupatadine, hydroxyzine, and cetirizine, in combination with alcohol, in healthy volunteers. Hum Psychopharmacol Clin Exp 21:13–26.
   PubMed Web of Science ®Google Scholar
• Bardocz, S., Grant, G., Brown, D.S., Pusztai, A. (1988). Putrescine as a source of instant energy in the small intestine of the rat. GUT 42:24–28.
   Google Scholar
• Barr, J., Weir, A.J., Brendel, K., Sipes, I.G. (1991). Liver slices in dynamic organ culture. II. An in vitro cellular technique for the study of integrated drug metabolism using human tissue. Xenobiotica 21:341–350.
   PubMed Web of Science ®Google Scholar
• Becquemont, L., Verstuyft, C., Kerb, R., Brinkmann, U., Lebot, M., Jaillon, P., et al. (2001). Effect of grapefruit juice on digoxin pharmacokinetics in humans. Clin Pharmacol Ther 70:311–316.
   PubMed Web of Science ®Google Scholar
• Bejinen, J.H., Schellens, H.M. (2004). Drug interactions in oncology. The Lancet Oncol 5:489–496.
   PubMed Web of Science ®Google Scholar
• Belchi-Hernandez, J., Florido-Lopez, J.F., Estrada-Rodriguez, J.L., Martinez-Alzamora, F., Lopez-Serrano, C., Ojeda-Casas, J.A. (1993). Sulphite-induced urticaria. Ann Allergy 71:230–232.
   PubMedGoogle Scholar
• Beyer, K., Morrow, E., Li, X.M., Bardina, L., Bannon, G.A., Burks, A.W., et al. (2001). Effects of cooking methods on peanut allergenicity. J Allergy Clin Immunol 107:1077–1081.
   PubMed Web of Science ®Google Scholar
• Bieganski, T., Kusche, J., Feussner, K.D., Hesterberg, R., Richter, H., Lorenz, W. (1980). Human intestinal diamine oxidase: substrate specificity and comparative inhibitor study. Agents Actions 10:108–110.
   Google Scholar
• Blackwell, B., Marley, E. (1969). Monoamine oxidase inhibition and intolerance to foodstuffs. Bibl Nutr Dieta 11:96–110.
   PubMedGoogle Scholar
• Boomsma, F., van Dijk, J., Bhaggoe, U.M., Bouhuizen, A.M., van den Meiracker, A.H. (2000). Variation in semicarbazide-sensitive amine oxidase activity in plasma and tissues of mammals. Comp Biochem Physiol C Toxicol Pharmacol 126:69–78.
   PubMed Web of Science ®Google Scholar
• Boot, J.D., De Haas, S.L., Van Gerven, J.M., De Smet, M., Leathem, T., Wagner, J., et al. (2008). MK-0873, a PDE4 inhibitor, does not influence the pharmacokinetics of theophylline in healthy male volunteers. Pulm Pharmacol Ther 21:573–577.
   PubMed Web of Science ®Google Scholar
• Bressler, R. (2006). Grapefruit juice and prescription drug interactions—exploring mechanisms of this interaction and potential toxicity for certain drugs. Geriatrics 61:12–18.
   PubMed Web of Science ®Google Scholar
• Brigelius-Flohé, R., Müller, C., Menard, J., Florian, S., Schmehl, K., Wingler, K. (2001). Functions of GI-GPx: lessons from selenium-dependent expression and intracellular localization. Biofactors 14:101–106.
   PubMed Web of Science ®Google Scholar
• Brzezinska-Blaszczyk, E. (1992). Histamine secretion form human mesenteric and adenoidal mast cells. Arch Immunol Ther Exp (Warsz) 40:97–102.
   PubMedGoogle Scholar
• Bueb, J.L., Mousli, M., Landry, Y. (1991). Molecular basis for cellular effects of naturally occurring polyamines. Agents Actions 33:84–87.
   PubMedGoogle Scholar
• Burdychova, R., Komprda, T. (2007). Biogenic amine-forming microbial communities in cheese. FEMS Microbiol Lett 276:149–155.
   PubMed Web of Science ®Google Scholar
• Burke, W.J., Li, S.W., Chung, H.D., Ruggiero, D.A., Kristal, B.S., Johnson, E.M., et al. (2004). Neurotoxicity of MAO metabolites of catecholamine neurotransmitters: role in neurodegenerative diseases. Neurotoxicology 25:101–115.
   PubMed Web of Science ®Google Scholar
• Buu, N.T., Lussier, C. (1989). Consequences of monoamine oxidase inhibition: increased vesicular accumulation of dopamine and norepinephrine and increased metabolism by catechol-O-methyltransferase and phenolsulfotransferase. Prog Neuropsychopharmacol Biol Psychiatry 13:563–568.
   PubMed Web of Science ®Google Scholar
• Calcabrini, A., Arancia, G., Marra, M., Crateri, P., Befani, O., Martone, A., Agastinelli, E. (2002). Enzymatic oxidation products of spermine induce greater cytotoxic effects on human multidrug-resistant colon carcinoma cells (LoVo) than on their wild-type counterparts. Int J Cancer 99:43–52.
   PubMed Web of Science ®Google Scholar
• Carlson, D.B., Perdew, G.H. (2002). A dynamic role for the Ah receptor in cell signaling? Insights from a diverse group of Ah receptor interacting proteins. J Biochem Mol Toxicol 16:317–325.
   PubMed Web of Science ®Google Scholar
• Carroccio, A., Wu, D., Cederbaum, A.I. (1994). Ethanol increases content and activity of human cytochrome P4502E1 in a transduced HepG2 cell line. Biochem Biophys Res Commun 203:727–733.
   PubMed Web of Science ®Google Scholar
• Cashman, J.R., Zhang, J. (2006). Human flavin-containing mono-oxygenases. Annu Rev Pharmacol Toxicol 46:65–100.
   PubMed Web of Science ®Google Scholar
• Castell, J.V., Jover, R., Martinez-Jimenez, C.P., Gomez-Lechon, M.J. (2006). Hepatocyte cell lines: their use, scope, and limitations in drug metabolism studies. Expert Opin Drug Metab Toxicol 2:183–212.
   PubMed Web of Science ®Google Scholar
• Cederbaum, A.I. (2006). CYP2E1–biochemical and toxicological aspects and role in alcohol-induced liver injury. Mt Sinai J Med 73:657–672.
   PubMed Web of Science ®Google Scholar
• Chaikin, P., Gillen, M.S., Malik, M., Pentikis, H., Rhodes, G.R., Roberts, D.J. (2005). Coadministration of ketoconazole with H1-antagonists ebastine and loratadine in healthy subjects: pharmacokinetic and pharmacodynamic effects. Br J Clin Pharmacol 59:346–354.
   PubMed Web of Science ®Google Scholar
• Chan, W.K., Delucchi, A.B. (2000). Resveratrol, a red wine constituent, is a mechanism-based inactivator of cytochrome P450 3A4. Life Sci 67:3103–3112.
   PubMed Web of Science ®Google Scholar
• Chang, S.C., Lin, C.W., Jiang, C.M., Chen, H.C., Shih, M.K., Chen, Y.Y., et al. (2009). Histamine production by bacilli bacteria, acetic bacteria, and yeast isolated from fruit wines. Food Sciences Technol 42:280–285.
   Web of Science ®Google Scholar
• Chang, T.K., Waxman, D.J. (2006). Synthetic drugs and natural products as modulators of constitutive androstane receptor (CAR) and pregnane X receptor (PXR). Drug Metab Rev 38:51–73.
   PubMed Web of Science ®Google Scholar
• Chatterjee, U., Mondal, G., Chakraborti, P., Patra, H.K., Chatterjee, B.P. (2006). Changes in the allergenicity during different preparations of Pomfret, Hilsa, Bhetki, and mackerel fish as illustrated by enzyme-linked immunosorbent assay and immunoblotting. Int Arch Allergy Immunol 141:1–10.
   PubMed Web of Science ®Google Scholar
• Chen, C. (2008). Physicochemical, pharmacological, and pharmacokinetic properties of the zwitterionic antihistamines cetirizine and levocetirizine. Curr Med Chem 15:2173–2191.
   PubMed Web of Science ®Google Scholar
• Cheung, C., Ma, X., Krausz, K.W., Kimura, S., Feigenbaum, L., Dalton, T.P., et al. (2005). Differential metabolism of 2- amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) in mice humanized for CYP1A1 and CYP1A2. Chem Res Toxicol 18:1471–1478.
   PubMed Web of Science ®Google Scholar
• Chiba, M., Xu, X., Nishime, J.A., Balani, S.K., Lin, J.H. (1997). Hepatic microsomal metabolism of montelukast, a potent leukotriene D4 receptor antagonist, in humans. Drug Metab Dispos 25:1022–1031.
   PubMed Web of Science ®Google Scholar
• Christian, K., Lang, M., Maurel, P., Raffalli-Mathieu, F. (2004). Interaction of heterogeneous nuclear ribonucleoprotein A1 with cytochrome P450 2A6 mRNA: implications for post-transcriptional regulation of the CYP2A6 gene. Mol Pharmacol 65:1405–1414.
   PubMed Web of Science ®Google Scholar
• Clifford, C.P., Adams, D.A., Murray, S., Taylor, G.W., Wilkins, M.R., Boobis, AR., et al. (1997). The cardiac effects of terfenadine after inhibition of its metabolism by grapefruit juice. Eur J Clin Pharmacol 52:311–315.
   PubMed Web of Science ®Google Scholar
• Cockroft, K.M., Meistrell, M., III, Zimmerman GA, Risucci, D., Bloom, O., Cerami, A., et al. (1996). Cerebroprotective effects of aminoguanidine in a rodent model of stroke. Stroke 27:1393–1398.
   PubMed Web of Science ®Google Scholar
• Cuthbert, M.F., Greenberg, M.P., Morley, S.W. (1969). Cough and cold remedies: a potential danger to patients on monoamine oxidase inhibitors. Br Med J 15:404–406.
   Google Scholar
• Cvetkovic, M., Leake, B., Fromm, M.F., Wilkinson, G.R., Kim, R.B. (1999). OATP and P-glycoprotein transporters mediate the cellular uptake and excretion of fexofenadine. Drug Metab Dispos 27:866–871.
   PubMed Web of Science ®Google Scholar
• Da Prada, M., Zürcher, G., Würthrich, I., Haefely, W.E. (1988). On tyramine, food beverages, and the reversible MAO inhibitor moclobemide. J Neural Transm 26(Suppl):33–56.
   Google Scholar
• Dale, H.D., Laidlaw, P.D. (1910). The physiological action of β-iminazolyl-ethylamine. J Physiol (Lond) 41:318–344.
   Google Scholar
• Das, R., Kanungo, M.S. (1982). Activity and modulation of ornithine decarboxylase and concentrations of polyamines in various tissues of rats as a function of age. Exp Gerontol 17:95–103.
   PubMed Web of Science ®Google Scholar
• de Graaf, IA., Draaisma, A.L., Schoeman, O., Fahy, G.M., Groothuis, G.M., Koster, H.J. (2007). Cryopreservation of rat precision-cut liver and kidney slices by rapid freezing and vitrification. Cryobiology 54:1–12.
   PubMed Web of Science ®Google Scholar
• de Jonge, ME., Huitema, A.D., van Dam, S.M., Beijnen, J.H., Rodenhuis, S. (2005). Significant induction of cyclophosphamide and thiotepa metabolism by phenytoin. Cancer Chemother Pharmacol 55:507–510.
   PubMed Web of Science ®Google Scholar
• De Kanter, R., De Jager, M.H., Draaisma, A.L., Jurva, J.U., Olinga, P., Meijer, D.K., et al. (2002). Drug-metabolizing activity of human and rat liver, lung, kidney, and intestine slices. Xenobiotica 32:349–362.
   PubMed Web of Science ®Google Scholar
• De Santi, C., Pietrabissa, A., Spisni, R., Mosca, F., Pacifici, G.M. (2000a). Sulphation of resveratrol, a natural product present in grapes and wine, in the human liver and duodenum. Xenobiotica 30:609–617.
   PubMed Web of Science ®Google Scholar
• De Santi, C., Pietrabissa, A., Spisni, R., Mosca, F., Pacifici, G.M. (2000b). Sulphation of resveratrol, a natural compound present in wine, and its inhibition by natural flavonoids. Xenobiotica 30:857–866.
   PubMed Web of Science ®Google Scholar
• De Wachter, E., Malfroot, A., De Schutter, I., Vanbesien, J., De Schepper, J. (2003). Inhaled budesonide induced Cushing’s syndrome in cystic fibrosis patients, due to drug inhibition of cytochrome P450. J Cyst Fibros 2:72–75.
   PubMedGoogle Scholar
• Deferme, S., Augustijns, P. (2003). The effect of food components on the absorption of P-gp substrates: a review. J Pharm Pharmacol 55:153–162.
   PubMed Web of Science ®Google Scholar
• Degner, D., Grohmann, R., Kropp, S., Rüther, E., Bender, S., Engel, R.R., et al. (2004). Severe adverse drug reactions of antidepressants: results of the German multicenter drug surveillance program AMSP. Pharmacopsychiatry 37(Suppl 1):S39–S45.
   PubMedGoogle Scholar
• Dekhuijzen, P.N., Koopmans, P.P. (2002). Pharmacokinetic profile of zafirlukast. Clin Pharmacokinet 41:105–114.
   PubMed Web of Science ®Google Scholar
• Devereux, W., Wang, Y., Stewart, T.M., Hacker, A., Smith, R., Frydman, B., et al. (2003) Induction of the PAOh1/SMO polyamine oxidase by polyamine analogues in human lung carcinoma cells. Cancer Chemother Pharmacol 52:383–390.
   PubMed Web of Science ®Google Scholar
• Devillier, P., Roche, N., Faisy, C. (2008). Clinical pharmacokinetics and pharmacodynamics of desloratadine, fexofenadine, and levocetirizine: a comparative review. Clin Pharmacokinet 47:217–230.
   PubMed Web of Science ®Google Scholar
• Dilger, K., Zheng, Z., Klotz, U. (1999). Lack of drug interaction between omeprazole, lansoprazole, pantoprazole, and theophylline. Br J Clin Pharmacol 48:438–444.
   PubMed Web of Science ®Google Scholar
• Dilger, K., Schwab, M., Fromm, M.F. (2004). Identification of budesonide and prednisone as substrates of the intestinal drug efflux pump P-glycoprotein. Inflamm Bowel Dis 10:578–583.
   PubMed Web of Science ®Google Scholar
• Dogan, A., Rao, A.M., Hatcher, J., Rao, V.L.R., Baskaya, M.K., Dempsey, R.J. (1999). Effects of MDL 72527, a specific inhibitor of polyamine oxidase, on brain edema, ischemic injury volume, and tissue polyamine levels in rats after temporary middle cerebral artery occlusion. J Neurochem 72:765–770.
   PubMed Web of Science ®Google Scholar
• Donato, M.T., Castell, J.V. (2003). Strategies and molecular probes to investigate the role of cytochrome P450 in drug metabolism: focus on in vitro studies. Clin Pharmacokinet 42:153–178.
   PubMed Web of Science ®Google Scholar
• Donato, M.T., Lahoz, A., Castell, J.V., Gómez-Lechón, M.J. (2008). Cell lines: a tool for in vitro drug metabolism studies. Curr Drug Metab 9:1–11.
   PubMed Web of Science ®Google Scholar
• Dorhout, B., van Faassen, A., van Beusekom, C.M., Kingma, A.W., de Hoog, E., Nagel, G.T., et al. (1997). Oral administration of deuterium-labelled polyamines to sucking rat pups: luminal uptake, metabolic fate, and effects on gastrointestinal maturation. Br J Nutr 78:639–654.
   PubMed Web of Science ®Google Scholar
• Down, G., Siederer, S., Lim, S., Daley-Yates, P. (2006). Clinical pharmacology of cilomilast. Clin Pharmacokinet 45:217–233.
   PubMed Web of Science ®Google Scholar
• Dresser, G.K., Bailey, D.G., Leake, B.F., Schwarz, U.I., Dawson, P.A., Freeman, D.J., et al. (2002). Fruit juices inhibit organic anion transporting polypeptide-mediated drug uptake to decrease the oral availability of fexofenadine. Clin Pharmacol Ther 71:11–20
   PubMed Web of Science ®Google Scholar
• Dresser, G.K., Bailey, D.G. (2003). The effects of fruit juices on drug disposition: a new model for drug interactions. Eur J Clin Invest. 33(Suppl 2):10–16.
   PubMedGoogle Scholar
• Dresser, G.K., Kim, R.B., Bailey, D.G. (2005). Effect of grapefruit juice volume on the reduction of fexofenadine bioavailability: possible role of organic anion transporting polypeptides. Clin Pharmacol Ther 77:170–177.
   PubMed Web of Science ®Google Scholar
• Duan, J.Z. (2007). Applications of population pharmacokinetics in current drug labeling. J Clin Pharmacy Ther 32:57–79.
   PubMed Web of Science ®Google Scholar
• Dufour, C., Dandrifosse, G., Forget, P., Vermesse, F., Romain, N., Lepoint, A. (1987). Spermine and spermidine induce intestinal maturation in the rat. Gastroenterology 95:112–116.
   Web of Science ®Google Scholar
• Dupont, H., Davies, D.S., Strolin Benedetti, M. (1987). Inhibition of cytochrome P-450 dependent oxidation reactions by MAO inhibitors in rat liver microsomes. Biochem Pharmacol 36:1651–1657.
   PubMed Web of Science ®Google Scholar
• Dürr, D., Stieger, B., Kullak-Ublick, G.A., Rentsch, K.M., Steinert, H.C., Meier, P.J., et al. (2000). St John’s wort induces intestinal P-glycoprotein/MDR1 and intestinal and hepatic CYP3A4. Clin Pharmacol Ther 68:598–604.
   PubMed Web of Science ®Google Scholar
• Edmondson, D.E., Binda, C., Mattevi, A. (2007). Structural insights into the mechanism of amine oxidation by monoamine oxidases A and B. Arch Biochem Biophys 464:269–276.
   PubMed Web of Science ®Google Scholar
• Edwards, D.J., Fitzsimmons, M.E., Schuetz, E., Yasuda, K., Ducharme, M.P., Warbasse, L.H., et al. (1999). 6’,7’- dihydroxybergamottin in grapefruit juice and Seville orange juice: effects on cyclosporin disposition, enterocyte CYP3A4, and P-glycoprotein. Clin Pharmacol Ther 65:237–244.
   PubMed Web of Science ®Google Scholar
• Edwards, R.J., Murray, B.P., Murray, S., Schulz, T., Neubert, D., Gant, T.W., et al. (1994). Contribution of CYP1A1 and CYP1A2 to the activation of heterocyclic amines in monkeys and human. Carcinogenesis 15:829–836.
   PubMed Web of Science ®Google Scholar
• Edwards, R.J., Price, R.J., Watts, P.S., Renwick, A.B., Tredger, J.M., Boobis, A.R., Lake, B.G. (2003). Induction of cytochrome P450 enzymes in cultured precision-cut human liver slices. Drug Metab Dispos 31:282–288.
   PubMed Web of Science ®Google Scholar
• Ek, M., Söderdahl, T., Küppers-Munther, B., Edsbagge, J., Andersson, T.B., Björquist, P., et al. (2007). Expression of drug metabolizing enzymes in hepatocyte-like cells derived from human embryonic stem cells. Biochem Pharmacol 74:496–503.
   PubMed Web of Science ®Google Scholar
• Ekins, S., Erickson, J.A. (2002). A pharmacophore for human pregnane X receptor ligands. Drug Metab Dispos 30:96–99.
   PubMed Web of Science ®Google Scholar
• Ekins, S., Chang, C., Mani, S., Krasowski, M.D., Reschly, E.J., Iyer, M., et al. (2007). Human pregnane X receptor antagonists and agonists define molecular requirements for different binding sites. Mol Pharmacol 72:592–603.
   PubMed Web of Science ®Google Scholar
• Elmore, B.O., Bollinger, J.A., Dooley, D.M. (2002). Human kidney diamine oxidase: heterologous expression, purification, and characterization. J Biol Inorg Chem 7:565–579.
   PubMed Web of Science ®Google Scholar
• EMEA. (1995). Note for Guidance on the Investigation of Drug Interactions (CPMP/EWP/560/95). Online at: www.emea.europa.eu/pdfs/human/ewp/056095en.pdf. Accessed 21 Jan 2009.
   Google Scholar
• EMEA. (2008). Concept Paper/Recommendation on the Need for Revision of (CHMP) Note for Guidance on the Investigation of Drug Interactions (CPMP/EWP/560/95). Online at: www.emea.europa.eu/pdfs/human/ewp/29793108en.pdf
   Google Scholar
• Ernst, E. (2005). The efficacy of herbal medicine—an overview. Fundam Clin Pharmacol. 19:405–409.
   PubMed Web of Science ®Google Scholar
• Faber, M.S., Jetter, A., Fuhr, U. (2005). Assessment of CYP1A2 activity in clinical practice: why, how, and when? Basic Clin Pharmacol Toxicol 97:125–134.
   PubMed Web of Science ®Google Scholar
• Fahmi, O.A., Boldt, S., Kish, M., Obach, R.S., Tremaine, L.M. (2008). Prediction of drug-drug interactions from in vitro induction data: application of the relative induction score approach using cryopreserved human hepatocytes. Drug Metab Dispos 36:1971–1974.
   PubMed Web of Science ®Google Scholar
• Farid, N.A., Payne, C.D., Small, D.S., Winters, K.J., Ernest, C.S., 2nd, Brandt, J.T. et al. (2007). Cytochrome P450 3A inhibition by ketoconazole affects prasugrel and clopidogrel pharmacokinetics and pharmacodynamics differently. Clin Pharmacol Ther 81:735–741.
   PubMed Web of Science ®Google Scholar
• Farkas, D., Greenblatt, D.J. (2008). Influence of fruit juices on drug disposition: discrepancies between in vitro and clinical studies. Expert Opin Drug Metab Toxicol 4:381–393.
   PubMed Web of Science ®Google Scholar
• Favreau, L.V., Johnson, W.W., Chu, I., Soares, A., Clement, R.P., White, R.E. (2003). Desloratadine is not transported by human organic anion transport polypeptide-A. European Academy of Allergology and Clinical Immunology (EAACI), abstract book:278–279 (No. 966).
   Google Scholar
• FDA. (1997). Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research, Center for Biologics Evaluation and Research. Guidance for Industry: Drug Metabolism/Drug Interaction Studies in the Drug Development Process: Studies In Vitro. Online at: www.fda.gov/cder/guidance/clin3.pdf (April 1997).
   Google Scholar
• FDA. (1999). Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research, Center for Biologics Evaluation and Research. Guidance for Industry: In Vivo Drug Metabolism/Drug Interaction Studies—Study Design, Data Analysis, and Recommendations for Dosing and Labeling. Online at: www.fda.gov/cber/gdlns/metabol.pdf (Nov 1999). Accessed 21 Jan 2009.
   Google Scholar
• FDA. (2006). Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research, Center for Biologics Evaluation and Research. Draft Guidance for Industry: Drug Interaction Studies—Study Design, Data Analysis, and Implications for Dosing and Labeling. Online at: www.fda.gov/cber/gdlns/interactstud.pdf (9/11/2006).
   Google Scholar
• Felton, J.S., Knize, M.G., Bennett, L.M., Malfatti, M.A., Colvin, M.E., Kulp, K.S. (2004). Impact of environmental exposures on the mutagenicity/carcinogenicity of heterocyclic amines. Toxicology 198:135–145.
   PubMed Web of Science ®Google Scholar
• Fisher, M.M., Munro, I. (1983). Life-threatening anaphylactoid reactions to muscle relaxants. Anesth Analg 62:559–564.
   PubMed Web of Science ®Google Scholar
• Florang, V.R., Rees, J.N., Brogden, N.K., Anderson, D.G., Hurley, T.D., Doorn, J.A. (2007). Inhibition of the oxidative metabolism of 3,4-dihydroxyphenylacetaldehyde, a reactive intermediate of dopamine metabolism, by 4-hydroxy-2-nonenal. Neurotoxicology 28:76–82.
   PubMed Web of Science ®Google Scholar
• Fogel, W.A., Lewinski, A., Jochem, J. (2007). Histamine in food: is there anything to worry about? Biochem Soc Trans 35:349–352.
   PubMed Web of Science ®Google Scholar
• Foisy, M.M., Yakiwchuk, E.M., Chiu, I., Singh, A.E. (2008). Adrenal suppression and Cushing’s syndrome secondary to an interaction between ritonavir and fluticasone: a review of the literature. HIV Med 9:389–396.
   PubMed Web of Science ®Google Scholar
• Fowler, S., Zhang, H. (2008). In vitro evaluation of reversible and irreversible cytochrome P450 inhibition: current status on methodologies and their utility for predicting drug-drug interactions. AAPS J 10:410–424
   PubMed Web of Science ®Google Scholar
• Fuhr, U., Klittich, K., Staib, A.H. (1993). Inhibitory effect of grapefruit juice and its bitter principal, naringenin, on CYP1A2 dependent metabolism of caffeine in man. Br J Clin Pharmacol 35:431–436.
   PubMed Web of Science ®Google Scholar
• Geha, R., Buckley, C.E., Greenberger, P., Patterson, R., Polmar, S., Saxon, A., et al. (1993). Aspartame is no more likely than placebo to cause urticaria/angioedema: results of a multicenter, randomized, double-blind, placebo-controlled, crossover study. J Allergy Clin Immunol 92:512–520.
   Google Scholar
• Geick, A., Eichelbaum, M., Burk, O. (2001). Nuclear receptor response elements mediate induction of intestinal MDR1 by rifampin. J Biol Chem 276:14581–14587.
   PubMed Web of Science ®Google Scholar
• Gervasini, G., Vizcaino, S., Carrillo, J.A., Caballero, M.J., Benitez, J. (2006). The effect of CYP2J2, CYP3A4, CYP3A5, and the MDR1 C3435Tpolymorphisms and gender on the urinary excretion of the metabolites of the H1-receptor antihistamine ebastine: a pilot study. Br J Clin Pharmacol 62:177–186.
   PubMed Web of Science ®Google Scholar
• Gómez-Lechón, M.J., Donato, T., Jover, R., Rodriguez, C., Ponsoda, X., Glaise, D., et al. (2001). Expression and induction of a large set of drug-metabolizing enzymes by the highly differentiated human hepatoma cell line BC2. Eur J Biochem 268:1448–1159.
   PubMedGoogle Scholar
• Goodman, D.L., McDonnell, J.T., Nelson, H.S., Vaughan, T.R., Weber, R.W. (1990). Chronic urticaria exacerbated by the antioxidant food preservatives, butylated hydroxyanizole (BHA), and butylated hydroxytoluene (BHT). J Allergy Clin Immunol 86:570–575.
   PubMed Web of Science ®Google Scholar
• Gorski, P. (1985). Polymyxin B-induced basophil degranulation in atopic and nonatopic asthmatic patients. Allergol Immunopathol (Madrid) 13:379–382.
   PubMedGoogle Scholar
• Gorski, P., Rozniecki, J., Kuzminska, B., Grzegorczyk, J. (1985). Bronchial and basophil reaction to polymyxin B in asthmatic patients. Allergy 40:70–72.
   PubMed Web of Science ®Google Scholar
• Gozalo Reques, F., Estrada Rodriguez, J.L. (1999). Tolerability of leukotriene modifiers in asthma: a review of clinical experience. BioDrugs 11:385–394.
   PubMed Web of Science ®Google Scholar
• Graham, M.J., Lake, B.G. (2008). Induction of drug metabolism: species differences and toxicological relevance. Toxicology 254:184–191.
   PubMed Web of Science ®Google Scholar
• Granneman, G.R., Braeckman, R.A., Locke, C.S., Cavanaugh, J.H., Dubé, L.M., Awni, W.M. (1995). Effect of zileuton on theophylline pharmacokinetics. Clin Pharmacokinet 29 (Suppl 2):77–83.
   PubMedGoogle Scholar
• Greco, W.R., Bravo, G., Parsons, J.C. (1995). The search for synergy: a critical review from a resonse surface perspective. Pharmacol Rev 47:331–385.
   PubMed Web of Science ®Google Scholar
• Gross-Steinmeyer, K., Stapleton, P.L., Tracy, J.H., Bammler, T.K., Lehman, T., Strom, S.C., et al. (2005). Influence of Matrigel-overlay on constitutive and inducible expression of nine genes encoding drug-metabolizing enzymes in primary human hepatocytes. Xenobiotica 35:419–438.
   PubMed Web of Science ®Google Scholar
• Grover, G.S., Brayman, T.G., Voorman, R.L., Ware, J.A. (2007). Development of in vitro methods to predict induction of CYP1A2 and CYP3A4 in humans. Assay Drug Dev Technol 5:793–804.
   PubMed Web of Science ®Google Scholar
• Gueant, J.L., Aimone-Gastin, I., Namour, F., Laroche, D., Bellou, A., Laxenaire, M.C. (1998). Diagnosis and pathogenesis of the anaphylactic and anaphylactoid reactions to anaesthetics. Clin Exp Allergy 28(Suppl 4):65–70.
   PubMedGoogle Scholar
• Guo, L.Q., Fukuda, K., Ohta, T., Yamazoe, Y. (2000). Role of furanocoumarin derivatives on grapefruit juice-mediated inhibition of human CYP3A activity. Drug Metab Dispos 28:766–771.
   PubMed Web of Science ®Google Scholar
• Gupta, S., Banfield, C., Kantesaria, B., Marino, M., Clement, R., Affrime, M., et al. (2001). Pharmacokinetic and safety profile of desloratadine and fexofenadine when coadministered with azithromycin: a randomized, placebo-controlled, parallel-group study. Clin Ther 23:451–466.
   PubMed Web of Science ®Google Scholar
• Hamelin, B.A., Bouayad, A., Drolet, B., Gravel, A., Turgeon, J. (1998). In vitro characterization of cytochrome P450 2D6 inhibition by classic histamine H1-receptor antagonists. Drug Metab Dispos 26:536–539.
   PubMed Web of Science ®Google Scholar
• Hamelin, B.A., Bouayad, A., Méthot, J., Jobin, J., Desgagnés, P., Poirier, P., et al. (2000). Significant interaction between the nonprescription antihistamine diphenhydramine and the CYP2D6 substrate metoprolol in healthy men with high or low CYP2D6 activity. Clin Pharmacol Ther 67:466–477.
   PubMed Web of Science ®Google Scholar
• Hariparsad, N., Carr, B.A., Evers, R., Chu, X. (2008). Comparison of immortalized Fa2N-4 cells and human hepatocytes as in vitro models for cytochrome P450 induction. Drug Metab Dispos 36:1046–1055.
   PubMed Web of Science ®Google Scholar
• Hart, S.N., Zhong, X.B. (2008). P450 oxidoreductase: genetic polymorphisms and implications for drug metabolism and toxicity. Expert Opin Drug Metab Toxicol 4:439–452.
   PubMed Web of Science ®Google Scholar
• Hasan, F., McCrodden, J.M., Kennedy, N.P., Tipton, K.F. (1988). The involvement of intestinal monoamine oxidase in the transport and metabolism of tyramine. J Neural Transm (Suppl) 26:1–9.
   Google Scholar
• Hayashi, S., Murakami, Y., Matsufuji, S. (1996). Ornithine decarboxylase antizyme: a novel type of regulatory protein. Trends Biochem Sci 21:27–30.
   PubMed Web of Science ®Google Scholar
• Hermann, R., Siegmund, W., Giessmann, T., Westphal, K., Weinbrenner, A., Hauns, B., et al. (2007). The oral, once-daily phosphodiesterase 4 inhibitor roflumilast lacks relevant pharmacokinetic interactions with inhaled budesonide. J Clin Pharmacol 47:1005–1013.
   PubMed Web of Science ®Google Scholar
• Hernandez, M., Solé, M., Boada, M., Unzeta, M. (2006). Soluble semicarbazide sensitive amine oxidase (SSAO) catalysis induces apoptosis in vascular smooth muscle cells. Biochim Biophys Acta 1763:164–173.
   PubMed Web of Science ®Google Scholar
• Hiroi, T., Imaoka, S., Funae, Y. (1998). Dopamine formation from tyramine by CYP2D6. Biochem Biophys Res Commun 249:838–843.
   PubMed Web of Science ®Google Scholar
• Holtbecker, N., Fromm, M.F., Kroemer, H.K., Ohnhaus, E.E., Heidemann, H. (1996). The nifedipine-rifampin interaction: evidence for induction of gut wall metabolism. Drug Metab Dispos 24:1121–1123.
   PubMed Web of Science ®Google Scholar
• Honig, P.K., Wortham, D.C., Hull, R., Zamani, K., Smith, J.E., Cantilena, L.R. (1993). Itraconazole affects single-dose terfenadine pharmacokinetics and cardiac repolarization pharmacodynamics. J Clin Pharmacol 33:1201–1206.
   PubMed Web of Science ®Google Scholar
• Honig, P.K., Wortham, D.C., Lazarev, A., Cantilena, L.R. (1996). Grapefruit juice alters the systemic bioavailability and cardiac repolarization of terfenadine in poor metabolizers of terfenadine. J Clin Pharmacol 36:345–351.
   PubMed Web of Science ®Google Scholar
• Horinouchi, Y., Abe, K., Kubo, K., Oka, M. (1993). Mechanisms of vancomycin-induced histamine release from rat peritoneal mast cells. Agents Actions 40:28–36.
   PubMedGoogle Scholar
• Horton, J.R., Sawada, K., Nishibori, M., Cheng, X. (2005). Structural basis for inhibition of histamine N-methyltransferase by diverse drugs. J Mol Biol 353:334–344.
   PubMed Web of Science ®Google Scholar
• Ingelman-Sundberg, M., Sim, S.C., Gomez, A., Rodriguez-Antona, C. (2007). Influence of cytochrome P450 polymorphisms on drug therapies: pharmacogenetic, pharmacoepigenetic, and clinical aspects. Pharmacol Ther 11:496–526.
   Google Scholar
• Ioannides, C. (2002). Pharmacokinetic interactions between herbal remedies and medicinal drugs. Xenobiotica 32:451–478.
   PubMed Web of Science ®Google Scholar
• Ionescu, G., Kiehl, R. (1988). Monoamine and diamine oxidase activities in atopic eczema. Allergy 43:318–319.
   PubMed Web of Science ®Google Scholar
• Izquierdo-Pulido, M. (1996). Biogenic amines in European beers. J Agric Food Chem 44:33159–33163.
   Google Scholar
• Izzo, A.A. (2004). Herb-drug interactions: an overview of the clinical evidence. Fundam Clin Pharmacol 19:1–16.
   Web of Science ®Google Scholar
• Jaakkola, T., Backman, J.T., Neuvonen, M., Niemi, M., Neuvonen, P.J. (2006). Montelukast and zafirlukast do not affect the pharmacokinetics of the CYP2C8 substrate pioglitazone. Eur J Clin Pharmacol., 62:503–509.
   PubMed Web of Science ®Google Scholar
• Jacobs, M.N., Dickins, M., Lewis, D.F. (2003). Homology modelling of the nuclear receptors: human oestrogen receptorbeta (hERbeta), the human pregnane-X-receptor (PXR), the Ah receptor (AhR), and the constitutive androstane receptor (CAR) ligand binding domains from the human oestrogen receptor alpha (hERalpha) crystal structure, and the human peroxisome proliferator activated receptor alpha (PPARalpha) ligand-binding domain from the human PPARgamma crystal structure. J Steroid Biochem Mol Biol 84:117–132.
   PubMed Web of Science ®Google Scholar
• Jänne, J., Raina, A., Siimes, M. (1964). Spermidine and spermine in rat tissues at different ages. Acta Physiol Scand 62:352–358.
   PubMedGoogle Scholar
• Johnson, S.R., Marion, A.A., Vrchoticky, T., Emmanuel, P.J., Lujan-Zilbermann, J. (2006). Cushing’s syndrome with secondary adrenal insufficiency from concomitant therapy with ritonavir and fluticasone. J Pediatr 148:386–388.
   PubMed Web of Science ®Google Scholar
• Johnson, W.W. (2008). Cytochrome P450 inactivation by pharmaceuticals and phytochemicals: therapeutic relevance. Drug Metab Rev 40:101–147.
   PubMed Web of Science ®Google Scholar
• Jonsson, G., Astrom, A., Andersson. (1995). Budesonide is metabolized by cytochrome P450 3A (CYP3A) enzymes in human liver. Drug Metab Dispos 23:137–142
   PubMed Web of Science ®Google Scholar
• Kajita, J., Inano, K., Fuse, E., Kuwabara, T., Kobayashi, H. (2002). Effects of olopatadine, a new antiallergic agent, on human liver microsomal cytochrome P450 activities. Drug Metab Dispos 30:1504–1511.
   PubMed Web of Science ®Google Scholar
• Kameoka, S.M., Leavitt, P.M., Chang, C., Kuo, S.M. (1999). Expression of antioxidant proteins in human intestinal Caco-2 cells treated with dietary flavonoids. Cancer Lett 146:161–167.
   PubMed Web of Science ®Google Scholar
• Kane, G.C., Lipsky, J.J. (2000). Drug-grapefruit juice interactions. Mayo Clin Proc 75:933–942.
   PubMed Web of Science ®Google Scholar
• Kanebratt, K.P., Andersson, T.B. (2008). HepaRG cells as an in vitro model for evaluation of cytochrome P450 induction in humans. Drug Metab Dispos 36:1137–1145.
   Google Scholar
• Karjalainen, M.J., Neuvonen, P.J., Backman, J.T. (2006). Rofecoxib is a potent, metabolism-dependent inhibitor of CYP1A2: implications for in vitro prediction of drug interactions. Drug Metab Dispos 34:2091–2096.
   PubMed Web of Science ®Google Scholar
• Kassahun, K., Skordos, K., McIntosh, I., Slaughter, D., Doss, G.A., Baillie, T.A., et al. (2005). Zafirlukast metabolism by cytochrome P450 3A4 produces an electrophilic alpha,beta-unsaturated iminium species that results in the selective mechanism-based inactivation of the enzyme. Chem Res Toxicol 18:1427–1437.
   PubMed Web of Science ®Google Scholar
• Katragadda, S., Budda, B., Anand, B.S., Mitra, A.K. (2005). Role of efflux pumps and metabolizing enzymes in drug delivery. Expert Opin Drug Deliv 2:683–705.
   PubMedGoogle Scholar
• Kawajiri, K., Fujii-Kuriyama, Y. (2007). Cytochrome P450 gene regulation and physiological functions mediated by the aryl hydrocarbon receptor. Arch Biochem Biophys 464:207–212.
   PubMed Web of Science ®Google Scholar
• Kawana, K., Ikuta, T., Kobayashi, Y., Gotoh, O., Takeda, K., Kawajiri, K. (2003). Molecular mechanism of nuclear translocation of an orphan nuclear receptor, SXR. Mol Pharmacol 63:524–531.
   PubMed Web of Science ®Google Scholar
• Kennedy, M.J., Loehle, J.A., Griffin, A.R., Doll, M.A., Kearns, G.L., Sullivan, J.E., et al. (2008). Association of the histamine N-methyltransferase C314T (Thr105Ile) polymorphism with atopic dermatitis in Caucasian children. Pharmacotherapy 8:1495–1501.
   Google Scholar
• Kenny, J.R., Chen, L., McGinnity, D.F., Grime, K., Shakesheff, K.M., Thomson, B., et al. (2008). Efficient assessment of the utility of immortalized Fa2N-4 cells for cytochrome P450 (CYP) induction studies using multiplex quantitative reverse transcriptase-polymerase chain reaction (qRT-PCR) and substrate cassette methodologies. Xenobiotica 38:1500–1517.
   PubMed Web of Science ®Google Scholar
• Kent, U.M., Aviram, M., Rosenblat, M., Hollenberg, P.F. (2002). The licorice root derived isoflavan glabridin inhibits the activities of human cytochrome P450s 3A4, 2B6, and 2C9. Drug Metab Dispos 30:709–715.
   PubMed Web of Science ®Google Scholar
• Kiehl, R., Ionescu, G. (1989). [Histamine-degrading enzymes in atopic eczema]. Z Hautkr 64:1121–1123.
   PubMedGoogle Scholar
• Koarai, A., Ichinose, M., Ishigaki-Suzuki, S., Yamagata, S., Sugiura, H., Sakurai, E., et al. (2003). Disruption of L-histidine decarboxylase reduces airway eosinophilia but not hyperresponsiveness. Am J Respir Crit Care Med 167:758–763.
   PubMed Web of Science ®Google Scholar
• Kobayash, K., Sueyoshi, T., Inoue, K., Moore, R., Negishi, M. (2003). Cytoplasmic accumulation of the nuclear receptor CAR by a tetratricopeptide repeat protein in HepG2 cells. Mol Pharmacol 64:1069–1075.
   PubMed Web of Science ®Google Scholar
• Kosoglu, T., Meyer, I., Veltri, E.P., Statkevich, P., Yang, B., Zhu, Y., et al. (2002). Pharmacodynamic interaction between the new selective cholesterol absorption inhibitor ezetimibe and simvastatin. Br J Clin Pharmacol 54:309–319.
   PubMed Web of Science ®Google Scholar
• Koyano, S., Kurose, K., Saito, Y., Ozawa, S., Hasegawa, R., Komamura, K., et al. (2004). Functional characterization of four naturally occurring variants of human pregnane X receptor (PXR): one variant causes dramatic loss of both DNA binding activity and the transactivation of the CYP3A4 promoter/enhancer region. Drug Metab Dispos 32:149–154.
   PubMed Web of Science ®Google Scholar
• Krueger, S.K., Williams, D.E. (2005). Mammalian flavin- containing mono-oxygenases: structure/function, genetic polymorphisms, and role in drug metabolism. Pharmacol Ther 106:357–387.
   PubMed Web of Science ®Google Scholar
• Kuefner, M.A., Schwelberger, H.G., Hahn, E.G., Raithel, M. (2008). Decreased histamine catabolism in the colonic mucosa of patients with colonic adenoma. Dig Dis Sci 53:436–442.
   PubMed Web of Science ®Google Scholar
• Kulczycki, A., Jr. (1986). Aspartame-induced urticaria. Ann Intern Med 104:207–208.
   PubMed Web of Science ®Google Scholar
• Kunduzova, O.R., Bianchi, P., Parini, A., Cambon, C. (2002). Hydrogen peroxide production by monoamine oxidase during ischemia/reperfusion. Eur J Pharmacol 448:225–230.
   PubMed Web of Science ®Google Scholar
• Kuramasu, A., Saito, H., Suzuki, S., Watanabe, T., Ohtsu, H. (1998). Mast cell-/basophil-specific transcriptional regulation of human L-histidine decarboxylase gene by CpG methylation in the promoter region. J Biol Chem 273:31607–31614.
   PubMed Web of Science ®Google Scholar
• Lahu, G., Huennemeyer, A., von Richter, O., Hermann, R., Herzog, R., McCracken, N., et al. (2008). Effect of single and repeated doses of ketoconazole on the pharmacokinetics of roflumilast and roflumilast N-oxide. J Clin Pharmacol 48:1339–1349.
   PubMed Web of Science ®Google Scholar
• Larqué, E., Sabater-Molina, M., Zamora, S. (2007). Biological significance of dietary polyamines. Nutrition 23:87–95.
   PubMed Web of Science ®Google Scholar
• Lee, C.R., Thrasher, K.A. (2001). Difficulties in anticoagulation management during coadministration of warfarin and rifampin. Pharmacotherapy 21:1240–1246.
   PubMed Web of Science ®Google Scholar
• Lee, Y.S., Lorenzo, B.J., Koufis, T., Reidenberg, M.M. (1996). Grapefruit juice and its flavonoids inhibit 11β-hydroxysteroid dehydrogenase. Clin Pharmacol Ther 59:62–71.
   PubMed Web of Science ®Google Scholar
• Lerche-Langrand, C., Toutain, H.J. (2000). Precision-cut liver slices: characteristics and use for in vitro pharmaco-toxicology. Toxicology 153:221–253.
   PubMed Web of Science ®Google Scholar
• Levy, J.H., Adelson, D., Walker, B. (1991). Wheal and flare responses to muscle relaxants in humans. Agents Actions 34:302–308.
   PubMedGoogle Scholar
• Lewis, D.F., Ito, Y. (2008). Human cytochromes P450 in the metabolism of drugs: new molecular models of enzyme-substrate interactions. Expert Opin Drug Metab Toxicol 4:1181–1186.
   PubMed Web of Science ®Google Scholar
• Lewis, D.F., Ito, Y., Goldfarb, P.S. (2006). Structural modelling of the human drug-metabolizing cytochromes P450. Curr Med Chem 13:2645–2652.
   PubMed Web of Science ®Google Scholar
• Lewis, D.F., Lake, B.G., Dickins, M. (2007). Quantitative structure- activity relationships (QSARs) in inhibitors of various cytochromes P450: the importance of compound lipophilicity. J Enzyme Inhib Med Chem 22:1–6.
   PubMed Web of Science ®Google Scholar
• Li, P., Callery, P.S., Gan, L-S., Balani, S.K. (2007a). Esterase inhibition attribute of grapefruit juice leading to a new drug interaction. Drug Metab Dispos 35:1023–1031.
   PubMed Web of Science ®Google Scholar
• Li, P., Callery, P.S., Gan, L-S., Balani, S.K. (2007b). Esterase inhibition by grapefruit juice flavonoids leading to a new drug interaction. Drug Metab Dispos 35:1203–1208.
   PubMed Web of Science ®Google Scholar
• Li, W., Yuan, X.M., Ivanova, S., Tracey, K.J., Eaton, J.W., Brunk, U.T. (2003). 3-aminopropanal, formed during cerebral ischaemia, is a potent lysosomotropic neurotoxin. Biochem J 371:429–436.
   PubMed Web of Science ®Google Scholar
• Lijinsky, W. (1999) N-nitroso compounds in the diet. Mutat Res 443:129–138.
   PubMed Web of Science ®Google Scholar
• Lin, J.H. (2006). CYP induction-mediated drug interactions: in vitro assessment and clinical implications. Pharm Res 23:1089–1116.
   PubMed Web of Science ®Google Scholar
• Lin, J., Cashman, J.R. (1997). Detoxication of tyramine by the flavin-containing mono-oxygenase: stereoselective formation of the transoxime. Chem Res Toxicol 10:842–852.
   PubMed Web of Science ®Google Scholar
• Liu, K.H., Kim, M.G., Lee, D.J., Yoon, Y.J., Kim, M.J., Shon, J.H., et al. (2006). Characterization of ebastine, hydroxyebastine, and carebastine metabolism by human liver microsomes and expressed cytochrome P450 enzymes: major roles for CYP2J2 and CYP3A. Drug Metab Dispos 34:1793–1797.
   PubMed Web of Science ®Google Scholar
• Lizcano, J.M., Tipton, K.F., Unzeta, M. (1998). Purification and characterization of membrane-bound semicarbazide-sensitive amine oxidase (SSAO) from bovine lung. Biochem J 331:69–78.
   PubMed Web of Science ®Google Scholar
• Lorenz, W., Thon, K., Barth, H., Neugebauer, E., Reimann, H.J., Kusche, J. (1983). Metabolism and function of gastric histamine in health and disease. J Clin Gastroenterol Suppl 1: 37–56.
   PubMedGoogle Scholar
• Lortie, M.J., Novotny, W.F., Peterson, O.W., Vallon, V., Malvey, K., Mendonca, M., et al. (1996). Agmatine, a bioactive metabolite of arginine. Production, degradation, and functional effects in the kidney of the rat. J Clin Invest 97:413–420.
   PubMed Web of Science ®Google Scholar
• Lu, P., Schrag, M.L., Slaughter, D.E., Raab, C.E., Shou, M., Rodrigues, A.D. (2003). Mechanism-based inhibition of human liver microsomal cytochrome P450 1A2 by zileuton, a 5-lipoxygenase inhibitor. Drug Metab Dispos 31:1352–1360.
   PubMed Web of Science ®Google Scholar
• Machinist, J.M., Mayer, M.D., Shet, M.S., Ferrero, J.L., Rodrigues, A.D. (1995). Identification of the human liver cytochrome P450 enzymes involved in the metabolism of zileuton (ABT-077) and its N-dehydroxylated metabolite, Abbott-66193. Drug Metab Dispos 23:1163–1174.
   PubMed Web of Science ®Google Scholar
• Maier, A., Zimmermann, C., Beglinger, C., Drewe, J., Gutmann, H. (2007). Effects of budesonide on P-glycoprotein expression in intestinal cell lines. Br J Pharmacol 150:361–368.
   PubMed Web of Science ®Google Scholar
• Maintz, L., Benfadal, S., Allam, J.P., Hagemann, T., Fimmers, R., Novak, N. (2006). Evidence for a reduced histamine degradation capacity in a subgroup of patients with atopic eczema. J Allergy Clin Immunol 117:1106–1112.
   PubMed Web of Science ®Google Scholar
• Maintz, L., Novak, N. (2007). Histamine and histamine intolerance. Am J Clin Nutr 85:1185–1196.
   PubMed Web of Science ®Google Scholar
• Malmstrom, K., Schwartz, J., Reiss, T.F., Sullivan, T.J., Reese, J.H., Jauregui, L., et al. (1998). Effect of montelukast on single-dose theophylline pharmacokinetics. Am J Ther 5:189–195.
   PubMedGoogle Scholar
• Mamune-Sato, R., Yamauchi, K., Tanno, Y., Ohkawara, Y., Ohtsu, H., Katayose, D., et, al. (1992). Functional analysis of alternatively spliced transcripts of the human histidine decarboxylase gene and its expression in human tissues and basophilic leukemia cells. Eur J Biochem 209:533–539.
   PubMedGoogle Scholar
• Manchee, G.R., Eddershaw, P.J., Ranshaw, L.E., Herriott, D., Park, G.R., Bayliss, M.K., et al. (1996). The aliphatic oxidation of salmeterol to alpha-hydroxysalmeterol in human liver microsomes is catalyzed by CYP3A. Drug Metab Dispos 24:555–559.
   PubMed Web of Science ®Google Scholar
• Marnett, L.J., Hurd, H.K., Hollstein, M.C., Levin, D.E., Esterbauer, H., Ames, B.N. (1985). Naturally occurring carbonyl compounds are mutagens in Salmonella tester strain TA104. Mutat Res 148:25–34.
   PubMed Web of Science ®Google Scholar
• Martignoni, M., Monshouwer, M., de Kanter, R., Pezzetta, D., Moscone, A., Grossi, P. (2004). Phase I and phase II metabolic activities are retained in liver slices from mouse, rat, dog, monkey, and human after cryopreservation. Toxicol In Vitro 18:121–128.
   PubMed Web of Science ®Google Scholar
• Martin, P., Riley, R., Back, D.J., Owen, A. (2008). Comparison of the induction profile for drug disposition proteins by typical nuclear receptor activators in human hepatic and intestinal cells. Br J Pharmacol 153:805–819.
   PubMed Web of Science ®Google Scholar
• Martinez, C., Agundez, J.A., Gervasini, G., Martin, R., Benitez, J. (1997). Tryptamine: a possible endogenous substrate for CYP2D6. Pharmacogenetics 7:85–93.
   PubMedGoogle Scholar
• Matsushima, S., Maeda, K., Hayashi, H., Debori, Y., Schinkel, A.H., Schuetz, J.D., et al. (2008a). Involvement of multiple efflux transporters in hepatic disposition of fexofenadine. Mol Pharmacol 73:1474–1483.
   PubMed Web of Science ®Google Scholar
• Matsushima, S., Maeda, K., Inoue, K., Ohta, K.Y., Yuasa, H., Kondo, T., et al. (2008b). The inhibition of human multidrug and toxin extrusion 1 (hMATE1) is involved in the drug-drug interaction caused by cimetidine. Drug Metab Dispos 2008 Dec 12. [Epub ahead of print]
   Web of Science ®Google Scholar
• Mattila, M.J., Kuitunen, T., Plétan, Y. (1992). Lack of pharmacodynamic and pharmacokinetic interactions of the antihistamine ebastine with ethanol in healthy subjects. Eur J Clin Pharmacol 43:179–184.
   PubMed Web of Science ®Google Scholar
• McGinnity, D.F., Berry, A.J., Kenny, J.R., Grime, K., Riley, R.J. (2006). Evaluation of time-dependent cytochrome P450 inhibition using cultured human hepatocytes. Drug Metab Dispos 34:1291–1300.
   PubMed Web of Science ®Google Scholar
• Mertens-Talcott, S.U., Zadezensky, I., De Castro, W.V., Derendorf, H., Butterweck, V. (2006). Grapefruit-drug interactions: can interactions with drugs be avoided? J Clin Pharmacol 46:1390–1416.
   PubMed Web of Science ®Google Scholar
• Michiels, C., Raes, M., Toussaint, O., Remacle, J. (1994). Importance of Se-glutathione peroxidase, catalase, and Cu/Zn-SOD for cell survival against oxidative stress. Free Radic Biol Med 17:235–248.
   PubMed Web of Science ®Google Scholar
• Milovic, V. (2001). Polyamines in the gut lumen: bioavailability and biodistribution. Eur J Gastroenterol Hepatol 13:1021–1025.
   PubMed Web of Science ®Google Scholar
• Min, D.I., Ku, Y.-.M., Geraets, D.R., Lee, H-C. (1996). Effect of grapefruit juice on the pharmacokinetics and pharmacodynamics of quinidine in healthy volunteers. J Clin Pharmacol 36:469–476.
   PubMed Web of Science ®Google Scholar
• Missbichler, A. (2004). Diagnostischer Nachweis der Aktivita¨t von Diaminooxidase in Serum oder Plasma. (Diagnostic proof of the DAO activity in serum and plasma.) In: Jarisch, R. (Ed.), Histamin-Intoleranz. Histamin, und Seekrankheit. (Histamine Intolerance. Histamine, and Motion Sickness.) (pp 8–17 ). Stuttgart, Germany: Georg Thieme Verlag KG.
   Google Scholar
• Mitchell, J.L., Simkus, C.L., Thane, T.K., Tokarz, P., Bonar, M.M., Frydman, B., et al. (2004). Antizyme induction mediates feedback limitation of the incorporation of specific polyamine analogues in tissue culture. Biochem J 384:271–279.
   PubMed Web of Science ®Google Scholar
• Mohri, K., Uesawa, Y., Sagawa, K-I. (2000). Effects of long-term grapefruit juice ingestion on nifedipine pharmacokinetics: induction of rat hepatic P-450 by grapefruit juice. Drug Metab Dispos 28:482–486.
   PubMed Web of Science ®Google Scholar
• Mondal, G., Chatterjee, U., Samanta, S., Chatterjee, B.P. (2007). Role of pepsin in modifying the allergenicity of bhetki (Lates calcarifer) and mackerel (Rastrelliger kanagurta) fish. Indian J Biochem Biophs 44:94–100.
   PubMed Web of Science ®Google Scholar
• Moneret-Vautrin, D.A., Kanny, G. (1993). Psedoallergic food reactions. In: Navarro, J., Schmitz, J. (Eds.), Foog allergies (pp 175–189 ). Paris, France: Doin Ed.
   Google Scholar
• Monneret, G., Benoit, Y., Gutowski, M.C., Bienvenu, J. (2000). Detection of basophil activation by flow cytometry in patients with allergy to muscle-relaxant drugs. Anesthesiology 92:275–277.
   PubMed Web of Science ®Google Scholar
• Moore, L.B., Goodwin, B., Jones, S.A., Wisely, G.B., Serabjit-Singh, C.J., Wilson, T.M., et al. (2000). St John’s wort induces hepatic drug metabolism through activation of the pregnane X receptor. Proc Natl Acad Sci U S A 97:7500–7502.
   PubMed Web of Science ®Google Scholar
• Morrow, J.D., Margolies, G.R., Rowland, J., Roberts, L.J. (1991). Evidence that histamine is the causative toxin of scombroid-fish poisoning. N Engl J Med 324:716–720.
   PubMed Web of Science ®Google Scholar
• Mougey, E.B., Feng, H., Castro, M., Irvin, C.G., Lima, J.J. (2009). Absorption of montelukast is transporter mediated: a common variant of OATP2B1 is associated with reduced plasma concentrations and poor response. Pharmacogenet Genomics 19:129–138.
   PubMed Web of Science ®Google Scholar
• Mourad, F.H., O’Donnell, L.J.D., Ogutu, E., Dias, J.A., Farthing, MJG. (1995). Role of 5-hydroxytryptamine in intestinal water and electrolyte movement during gut anaphylaxis. Gut 36:553–557.
   PubMed Web of Science ®Google Scholar
• Murray-Stewart, T., Wang, Y., Devereux, W., Casero, R.A. (2002). Cloning and characterization of multiple human polyamine oxidase splice variants that code for isoenzymes with different biochemical characteristics. Biochem J 368:673–677.
   Google Scholar
• Murray-Stewart, T., Wang, Y., Goodwin, A., Hacker, A., Meeker, A., Casero, R.A. (2008). Nuclear localization of human spermine oxidase isoforms—possible implications in drug response and disease etiology. FEBS J 275:2795–2806.
   PubMed Web of Science ®Google Scholar
• Musial, A., Bajda, M., Malawska, B. (2007). Recent developments in cholinesterases inhibitors for Alzheimer’s disease treatment. Curr Med Chem 14:2654–2679.
   PubMed Web of Science ®Google Scholar
• Naef, R., Schmid, C., Hofer, M., Minder, S., Speich, R., Boehler, A. (2007). Itraconazole comedication increases systemic levels of inhaled fluticasone in lung transplant recipients. Respiration 74:418–422.
   PubMed Web of Science ®Google Scholar
• Nassr, N., Lahu, G., von Richter, O., Reutter, F., Knoerzer, D., Zech, K., et al. (2007). Lack of a pharmacokinetic interaction between steady-state roflumilast and single-dose midazolam in healthy subjects. Br J Clin Pharmacol 63:365–370.
   PubMed Web of Science ®Google Scholar
• Niemi, M. (2007). Role of OATP transporters in the disposition of drugs. Pharmacogenomics 8:787–802.
   PubMed Web of Science ®Google Scholar
• Nishimura, M., Koeda, A., Shimizu, T., Nakayama, M., Satoh, T., Narimatsu, S., et al. (2008). Comparison of inducibility of sulfotransferase and UDP-glucuronosyltransferase mRNAs by prototypical microsomal enzyme inducers in primary cultures of human and cynomolgus monkey hepatocytes. Drug Metab Pharmacokinet 23:45–53.
   PubMed Web of Science ®Google Scholar
• Nishimura, K., Shiina, R., Kashiwagi, K., Igarashi, K. (2006). Decrease in polyamines with aging and their ingestion from food and drink. J Biochem 139:81–90.
   PubMed Web of Science ®Google Scholar
• Nivoix, Y., Levêque, D., Herbrecht, R., Koffel, J.C., Beretz, L., Ubeaud-Sequier, G. (2008). The enzymatic basis of drug-drug interactions with systemic triazole antifungals. Clin Pharmacokinet 47:779–792.
   PubMed Web of Science ®Google Scholar
• Niwa, T., Murayama, N., Yamazaki, H. (2008). Heterotropic cooperativity in oxidation mediated by cytochrome P450. Curr Drug Metab 9:453–962.
   PubMed Web of Science ®Google Scholar
• Norn, S. (1971). Anaphylactic histamine release and influence of antirheumatics. Acta Pharmacol Toxicol (Copenh) 30:3–59.
   PubMedGoogle Scholar
• Nowack, R. (2008). Cytochrome P450 enzyme, and transport protein-mediated herb-drug interactions in renal transplant patients: grapefruit juice, St John’s wort—and beyond! Nephrology 13:319–326.
   Google Scholar
• O’Reilly, R.A. (1975). Interaction of chronic daily warfarin therapy and rifampin. Ann Intern Med 83:506–508.
   PubMed Web of Science ®Google Scholar
• Obach, R., Walsky, R.L., Venkatakrishnan, K., Gaman, E.A., Houston, J., Tremaine, L.M. (2006). The utility of in vitro cytochrome P450 inhibition data in the prediction of drug-drug interactions. J Pharmac Exp Ther 316:336–348.
   PubMed Web of Science ®Google Scholar
• Obach, R.S., Walsky, R.L., Venkatakrishnan, K. (2007). Mechanism-based inactivation of human cytochrome P450 enzymes and the prediction of drug-drug interactions. Drug Metab Dispos 35:246–255.
   PubMed Web of Science ®Google Scholar
• Obradovic, T., Dobson, G.G., Shingaki, T., Kungu, T., Hidalgo, I.J. (2007). Assessment of the first- and second-generation antihistamines brain penetration and role of P-glycoprotein. Pharm Res 24:318–327.
   PubMed Web of Science ®Google Scholar
• O’Brien, P.J., Siraki, A.G., Shangari, N. (2005). Aldehyde sources, metabolism, molecular toxicity mechanisms, and possible effects on human health. Crit Rev Toxicol 35:609–662.
   PubMed Web of Science ®Google Scholar
• Ohmori, K., Hasegawa, K., Tamura, T., Miyake, K., Matsubara, M., Masaki, S., et al. (2004). Properties of olopatadine hydrochloride, a new antiallergic/antihistaminic drug. Arzneimittelforschung 54:809–829.
   PubMed Web of Science ®Google Scholar
• Olinga, P., Elferink, M.G., Draaisma, A.L., Merema, M.T., Castell, J.V., Pérez, G., et al. (2008). Coordinated induction of drug transporters and phase I and II metabolism in human liver slices. Eur J Pharm Sci 33:380–389.
   PubMed Web of Science ®Google Scholar
• Orans, J., Teotico, D.G., Redinbo, M.R. (2005). The nuclear xenobiotic receptor pregnane X receptor: recent insights and new challenges. Mol Endocrinol 19:2891–2900.
   PubMed Web of Science ®Google Scholar
• Osborne, D., Seidel, E.R. (1990). Gastrointestinal luminal polyamines: cellular accumulation and enterohepatic circulation. Am J Physiol Gastrointest Liver Physiol 258:G576–G584.
   Web of Science ®Google Scholar
• O’Sullivan, J., Unzeta, M., Healy, J., O’Sullivan, M.I., Davey, G., Tipton, K.F. (2004). Semicarbazide-sensitive amine oxidases: enzymes with quite a lot to do. Neurotoxicology 25:303–315.
   PubMed Web of Science ®Google Scholar
• Pacifici, G.M., Donatelli, P., Giuliani, L. (1992). Histamine N-methyl transferase: inhibition by drugs. Br J Clin Pharmacol 34:322–327.
   PubMed Web of Science ®Google Scholar
• Paine, M.F., Hart, H.L., Ludington, S.S., Haining, R.L., Rettie, A.E., Zeldin, D.C. (2006). The human intestinal cytochrome P450 “pie.” Drug Metab Dispos 34:880–886.
   PubMed Web of Science ®Google Scholar
• Paiva, T.B., Tominaga, M., Paiva, A.C. (1970). Ionization of histamine, N-acetylhistamine, and their iodinated derivatives. J Med Chem 13:689–692.
   PubMed Web of Science ®Google Scholar
• Patat, A., Ulliac, N., Zieleniuk, I., Stubbs, D., Dunmore, C., Sexton, B., et al. (1995). Lack of interaction between two antihistamines, mizolastine and cetirizine, and ethanol in psychomotor and driving performance in healthy subjects. Eur J Clin Pharmacol 48:143–150.
   PubMed Web of Science ®Google Scholar
• Pavek, P., Dvorak, Z. (2008). Xenobiotic-induced transcriptional regulation of xenobiotic metabolizing enzymes of the cytochrome P450 superfamily in human extrahepatic tissues. Curr Drug Metab 9:129–143.
   PubMed Web of Science ®Google Scholar
• Pearce, R.E., Leeder, J.S., Kearns, G.L. (2006). Biotransformation of fluticasone: in vitro characterization. Drug Metab Dispos 34:1035–1040.
   PubMed Web of Science ®Google Scholar
• Pegg, A.E. (2008). Spermidine/spermine-N(1)-acetyltransferase: a key metabolic regulator. Am J Physiol Endocrinol Metab 294:E995–E1010.
   PubMed Web of Science ®Google Scholar
• Pelkonen, O., Kapitulnik, J., Gundert-Remy, U., Boobis, A.R., Stockis, A. (2008a). Local kinetics and dynamics of xenobiotics. Crit Rev Toxicol 38:697–720.
   PubMed Web of Science ®Google Scholar
• Pelkonen, O., Turpeinen, M., Hakkola, J., Honkakoski, P., Hukkanen, J., Raunio, H. (2008b). Inhibition and induction of human cytochrome P450 enzymes: current status. Arch Toxicol 82:667–715.
   PubMed Web of Science ®Google Scholar
• Persson, K.P., Ekehed, S., Otter, C., Lutz, E.S., McPheat, J., Masimirembwa, C.M., et al. (2006). Evaluation of human liver slices and reporter gene assays as systems for predicting the cytochrome P450 induction potential of drugs in vivo in humans. Pharm Res 23:56–69.
   PubMed Web of Science ®Google Scholar
• Petersen, J., Raithel, M., Schwelberger, H.G. (2005). Characterization of functional polymorphisms of the human diamine oxidase gene. Inflamm Res 54(Suppl):S69–S70.
   Google Scholar
• Peytavin, G., Gautran, C., Otoul, C., Cremieux, A.C., Moulaert, B., Delatour, F., et al. (2005). Evaluation of pharmacokinetic interaction between cetirizine and ritonavir, an HIV-1 protease inhibitor, in healthy male volunteers. Eur J Clin Pharmacol 61:267–273.
   PubMed Web of Science ®Google Scholar
• Pfau, W., Marquardt, H. (2001). Cell transformation in vitro by food-derived heterocyclic amines Trp-P-1, Trp-P-2, and N2-OH-PhIP. Toxicology 166:25–30.
   PubMed Web of Science ®Google Scholar
• Phillips, I.R., Shephard, E.A. (2008). Flavin-containing mono- oxygenases: mutations, disease, and drug response. Trends Pharmacol Sci 29:294–301.
   PubMed Web of Science ®Google Scholar
• Prescott, L.F. (2000). Paracetamol, alcohol, and the liver. Br J Clin Pharmacol 49:291–301.
   PubMed Web of Science ®Google Scholar
• Purcell, W.M., Doyle, K.M., Bagga, L., Derks, M. (1994). Histamine release from mast cells by polyamines: an NMDA receptor- mediated event? Biochem Soc Trans 22:398S.
   PubMed Web of Science ®Google Scholar
• Pustylnyak, V.O., Lebedev, A.N., Gulyaeva, L.F., Lyakhovich, V.V., Slynko, N.M. (2007). Comparative study of CYP2B induction in the liver of rats and mice by different compounds. Life Sci 80:324–328.
   PubMed Web of Science ®Google Scholar
• Raaska, K., Niemi, M., Neuvonen, M., Neuvonen, P.J., Kivistö, K.T. (2002). Plasma concentrations of inhaled budesonide and its effects on plasma cortisol are increased by the cytochrome P4503A4 inhibitor itraconazole. Clin Pharmacol Ther 72:362–369.
   PubMed Web of Science ®Google Scholar
• Raeissi, S.D., Hidalgo, I.J., Segura-Aguilar, J., Artursson, P. (1999). Interplay between CYP3A-mediated metabolism and polarized efflux of terfenadine and its metabolites in intestinal epithelial Caco-2 (TC7) cell monolayers. Pharm Res 16:625–632.
   PubMed Web of Science ®Google Scholar
• Ramaswamy, S.G., Jakoby, W.B. (1987). Amine N-sulfotransferase. J Biol Chem 262:10039–10043.
   PubMed Web of Science ®Google Scholar
• Rasmussen, B.B., Jeppesen, U., Gaist, D., Brøsen, K. (1997). Griseofulvin and fluvoxamine interactions with the metabolism of theophylline. Ther Drug Monit 19:56–62.
   PubMed Web of Science ®Google Scholar
• Rasmussen, B.B., Maënpää, J., Pelkonen, O., Loft, S., Poulsen, H.E., Lykkesfeldt, J., Brøsen, K. (1995). Selective serotonin reuptake inhibitors and theophylline metabolism in human liver microsomes: potent inhibition by fluvoxamine. Br J Clin Pharmacol 39:151–159.
   PubMed Web of Science ®Google Scholar
• Regunathan, S., Reis, J. (2000). Characterization of arginine decarboxylase in rat brain and liver: distinction from ornithine decarboxylase. J Neurochem 74:2201–2208.
   PubMed Web of Science ®Google Scholar
• Reichmuth, D., Lockey, R.F. (2000). Present and potential therapy for allergic rhinitis: a review. BioDrugs 14:371–387.
   PubMed Web of Science ®Google Scholar
• Richard, N., Pivarnik, L., Ellis, P.C., Lee, C. (2008). Effect of matrix on recovery of biogenic amines in fish. J AOAC Int 91:768–776.
   PubMed Web of Science ®Google Scholar
• Rohatagi, S., Appajosyula, S., Derendorf, H., Szefler, S., Nave, R., Zech, K., et al. (2004). Risk-benefit value of inhaled glucocorticoids: a pharmacokinetic/pharmacodynamic perspective. J Clin Pharmacol 44:37–47.
   PubMed Web of Science ®Google Scholar
• Samara, E., Cavanaugh, J.H., Mukherjee, D., Granneman, G.R. (1995). Lack of pharmacokinetic interaction between zileuton and phenytoin in humans. Clin Pharmacokinet 29 (Suppl 2):84–91.
   PubMedGoogle Scholar
• Sasaki, M., Joh, T. (2007). Oxidative stress and ischemia-reperfusion injury in gastrointestinal tract and antioxidant, protective agents. J Clin Biochem Nutr 40:1–12.
   PubMed Web of Science ®Google Scholar
• Sattler, J., Hafner, D., Klotter, H.J., Lorenz, W., Wagner, P.K. (1988). Food-induced histaminosis as a epidemiological problem: plasma histamine elevation and haemodynamic alterations after oral histamine administration and blockade of diamine oxidase (DAO). Agents Actions 23:361–365.
   PubMedGoogle Scholar
• Sattler, J., Hesterberg, R., Lorenz, W., Schmidt, U., Crombach, M., Stahlknecht, C.D. (1985). Inhibition of human and canine diamine oxidase by drugs used in an intensive care unit: relevance for clinical side-effects? Agents Actions 16:91–94.
   PubMedGoogle Scholar
• Sattler, J., Lorenz, W., Kubo, K., Schmal, A., Sauer, S., Luben, L. (1989). Food-induced histaminosis under diamine oxidase (DAO) blockade in pigs: further evidence of the key role of elevated plasma histamine levels as demonstrated by successful prophylaxis with antihistamines. Agents Actions 27:212–214.
   PubMedGoogle Scholar
• Scandlyn, M.J., Stuart, E.C., Rosengren, R.J. (2008). Sex-specific differences in CYP450 isoforms in humans. Expert Opin Drug Metab Toxicol 4:413–424.
   PubMed Web of Science ®Google Scholar
• Schaad, N. (2002). Risks of interaction between drugs, grapefruit juice and red wine. Médecine Hygiène. 2385:665–668.
   Google Scholar
• Schleip, T. Cited by Missbichler A. (2004). Online at: www.nutritionlondon.net/phdi/p1.nsf/supppages/1012?opendocument&part=4. Accessed 15 January 2009.
   Google Scholar
• Schuster, D., Laggner, C., Steindl, T.M., Langer, T. (2006). Development and validation of an in silico P450 profiler based on pharmacophore models. Curr Drug Discov Technol 3:1–48.
   PubMedGoogle Scholar
• Schwarz, U.I., Leake, B.F., Kim, R.B., Whomsley, R., Strolin Benedetti, M. (2006). Role of OATP and OAT transporters in levocetirizine cellular uptake. Drug Metab. Rev 38(Suppl 2): 239 (No. 367).
   Google Scholar
• Schweitzer, J.W., Friedhoff, A.J., Schwartz, R. (1975). Chocolate, beta-phenethylamine, and migraine re-examined. Nature 257:256.
   PubMed Web of Science ®Google Scholar
• Schwelberger, H.G., Bodner, E. (1997). Purification and characterization of diamine oxidase from porcine kidney and intestine. Biochem Biophys Acta 1340:152–164.
   PubMed Web of Science ®Google Scholar
• Schwelberger, H.G. (2004). Diamine oxidase (DAO) enzyme and gene. In: Falus, A. (Ed.), Histamine: Biology and Medical Aspects. (pp 43–52 ). Budapest, Hungary: SpringMed Publishing.
   Google Scholar
• Schwelberger, H.G. (2007). The origin of mammalian plasma amine oxidases. J Neural Transm 114:757–762.
   PubMed Web of Science ®Google Scholar
• Seiler, N. (2004). Catabolism of polyamines. Amino Acids 26:217–233.
   PubMed Web of Science ®Google Scholar
• Seiler, N., Raul, F. (2007). Polyamines and the intestinal tract. Crit Rev Clin Lab Sci 44:365–411.
   PubMed Web of Science ®Google Scholar
• Seiler, N., Duranton, B., Gosse, F., Raul, F. (2000). Spermine cytotoxicity to human colon carcinoma-derived cells (Caco-2). Cell Biol Toxicol 16:117–130.
   PubMed Web of Science ®Google Scholar
• Sen, N.P. (1969). Analysis and significance of tyramine in foods. J Food Sci 34:22–26.
   Web of Science ®Google Scholar
• Shader, R.I., Granda, B.W., von Moltke, LL, Giancarlo, G.M., Greenblatt, D.J. (1999). Inhibition of human cytochrome P450 isoforms in vitro by zafirlukast. Biopharm Drug Dispos 20:385–388.
   PubMed Web of Science ®Google Scholar
• Shan, L., Vincent, J., Brunzelle, J.S., Dussault, I., Lin, M., Ianculescu, I., et al. (2004). Structure of the murine constitutive androstane receptor complexed to androstenol: a molecular basis for inverse agonism. Mol Cell 16:907–917.
   PubMed Web of Science ®Google Scholar
• Sharmin, S., Sakata, K., Kashiwagi, K., Ueda, S., Iwasaki, S., Shirahata, A., et al. (2001). Polyamine cytotoxicity in the presence of bovine serum amine oxidase. Biochem Biophys Res Commun 282:228–235.
   PubMed Web of Science ®Google Scholar
• Sharpe, J.G., Seidel, E.R. (2005). Polyamines are absorbed through a y+ amino acid carrier in rat intestinal epithelial cells. Amino Acids 29:245–253.
   PubMed Web of Science ®Google Scholar
• Shen, S., He, Y., Zeng, S. (2007). Stereoselective regulation of MDR1 expression in Caco-2 cells by cetirizine enantiomers. Chirality 19;485–490.
   PubMed Web of Science ®Google Scholar
• Shiga, T., Hashiguchi, M., Urae, A., Kasanuki, H., Rikihisa, T. (2000). Effect of cimetidine and probenecid on pilsicainide renal clearance in humans. Clin Pharmacol Ther 67:222–228.
   PubMed Web of Science ®Google Scholar
• Shimizu, M., Uno, T., Sugawara, K., Tateishi, T. (2006). Effects of itraconazole and diltiazem on the pharmacokinetics of fexofenadine, a substrate of P-glycoprotein. Br J Clin Pharmacol 61:538–544.
   PubMed Web of Science ®Google Scholar
• Silla Santos, M.H. (1996). Biogenic amines: their importance in foods. Int J Food Microbiol 29:213–231.
   PubMed Web of Science ®Google Scholar
• Simon, L., Szilagyi, G., Bori, Z., Orbay, P., Nagy, Z. (2001). (-)-D-Deprenyl attenuates apoptosis in experimental brain ischaemia. Eur J Pharmacol 430:235–241.
   PubMed Web of Science ®Google Scholar
• Simons, E.F.R., Simons, K.J. (1991). Pharmacokinetic optimisation of histamine H1-receptor antagonist therapy. Clin Pharmacokin 21:372–393.
   PubMed Web of Science ®Google Scholar
• Sinz, M., Wallace, G., Sahi, J. (2008). Current industrial practices in assessing CYP450 enzyme induction: preclinical and clinical predicting induction. AAPS J 10:391–400.
   PubMed Web of Science ®Google Scholar
• Smith, M.J., Garrett, R.H. (2005). A heretofore undisclosed crux of eosinophilia-myalgia syndrome: compromised histamine degradation. Inflamm Res 54:435–450.
   PubMed Web of Science ®Google Scholar
• Song, B.J., Veech, R.L., Park, S.S., Gelboin, H.V., Gonzalez, F.J. (1989). Induction of rat hepatic N-nitrosodimethylamine demethylase by acetone is due to protein stabilization. J Biol Chem 264:3568–3572.
   PubMed Web of Science ®Google Scholar
• Sperber, A.D. (1991). Toxic interaction between fluvoxamine and sustained release theophylline in an 11-year-old boy. Drug Saf 6:460–462.
   PubMed Web of Science ®Google Scholar
• Squires, E.J., Sueyoshi, T., Negishi, M. (2004). Cytoplasmic localization of pregnane X receptor and ligand-dependent nuclear translocation in mouse liver. J Biol Chem 279:49307–49314.
   PubMed Web of Science ®Google Scholar
• St Germain, R.M., Yigit, S., Wells, L., Girotto, J.E., Salazar, J.C. (2007). Cushing’s syndrome and severe adrenal suppression caused by fluticasone and protease inhibitor combination in an HIV-infected adolescent. AIDS Patient Care STDS 21:373–377.
   PubMed Web of Science ®Google Scholar
• Steen, D. (2004). Immortalized human hepatocytes: a new advance in convenience and performance. Curr Separat 20:137–140.
   Google Scholar
• Stein, C.M. (2002). Are herbal products dietary supplements or drugs? An important question for public safety. Clin Pharmacol Ther 71:411–413.
   PubMed Web of Science ®Google Scholar
• Steinhoff, M., Griffits, C., Church, M., Lugar, T.A. (2004). Histamine. In: Burns, T., Breathnach, S., Cox, N., Griffiths, C. (Eds.), Rook’s Textbook of Dermatology (pp 50–52 ). Oxford, United Kingdom: Blackwell Science.
   Google Scholar
• Strolin Benedetti, M., Tipton, K., Whomsley, R. (2007). Amine oxidases and mono-oxygenases in the in vivo metabolism of xenobiotic amines in humans: has the involvment of amine oxidases been neglected? Fund Clin Pharmacol 21:467–479.
   PubMed Web of Science ®Google Scholar
• Strolin Benedetti, M., Boucher, T., Carlsson, A., Fowler, C.J. (1983). Intestinal metabolism of tyramine by both forms of monoamine oxidase in the rat. Biochem Pharmacol 32:47–52.
   PubMed Web of Science ®Google Scholar
• Sugimura, T. (2000). Nutrition and dietary carcinogens. Carcinogenesis 21:387–395.
   PubMed Web of Science ®Google Scholar
• Suino, K., Peng, L., Reynolds, R., Li, Y., Cha, J.Y., Repa, J.J., et al. (2004). The nuclear xenobiotic receptor CAR: structural determinants of constitutive activation and heterodimerization. Mol Cell 16:893–905.
   PubMed Web of Science ®Google Scholar
• Suzuki, A., Yasui-Furukori, N., Mihara, K., Kondo, T., Furukori, H., Inoue, Y., et al. (2003). Histamine H1-receptor antagonists, promethazine, and homochlorcyclizine, increase the steady-state plasma concentrations of haloperidol and reduced haloperidol. Ther Drug Monit 25:192–196.
   PubMed Web of Science ®Google Scholar
• Szöko, E., Tábi, T., Borbás, T., Dalmadi, B., Tihanyi, K., Magyar, K. (2004). Assessment of the N-oxidation of deprenyl, methamphetamine, and amphetamine enantiomers by chiral capillary electrophoresis: an in vitro metabolism study. Electrophoresis 25:2866–2875.
   PubMed Web of Science ®Google Scholar
• Tada, Y., Tsuda, Y., Otsuka, T., Nagasawa, K., Kimura, H., Kusaba, T., et al. (1992). Case report: nifedipine-rifampicin interaction attenuates the effect on blood pressure in a patient with essential hypertension. Am J Med Sci 303:25–27.
   PubMed Web of Science ®Google Scholar
• Tahara, H., Kusuhara, H., Maeda, K., Koepsell, H., Fuse, E., Sugiyama, Y. (2006). Inhibition of OAT3 mediated renal uptake as a mechanism for drug-drug interaction between foxofenadine and probenecid. Drug Metab Dispos 34:743–747.
   PubMed Web of Science ®Google Scholar
• Takagi, S., Nakajima, M., Mohri, T., Yokoi, T. (2008). Post-transcriptional regulation of human pregnane X receptor by micro-RNA affects the expression of cytochrome P450 3A4. J Biol Chem 283:9674–9680.
   PubMed Web of Science ®Google Scholar
• Tanel, A., Averill-Bates, D.A. (2007). Activation of the death receptor pathway of apoptosis by the aldehyde acrolein. Free Radic Biol Med 42:798–810.
   PubMed Web of Science ®Google Scholar
• Tang, W., Wang, R.W., Lu, A.Y. (2005). Utility of recombinant cytochrome P450 enzymes: a drug metabolism perspective. Curr Drug Metab 6:503–517.
   PubMed Web of Science ®Google Scholar
• Tarlo, S.M., Sussman, G.L. (1993). Asthma and anaphylactoid reactions to food additives. Can Fam Physician 39:1119–1123.
   PubMed Web of Science ®Google Scholar
• Tarrus, E., Cami, J., Roberts, D.J., Spickett, R.G., Celdran, E., Segura, J. (1987). Accumulation of caffeine in healthy volunteers treated with furafylline. Br J Clin Pharmacol 23:9–18.
   PubMed Web of Science ®Google Scholar
• Ten Eick, A.P., Blumer, J.L., Reed, M.D. (2001). Safety of antihistamines in children. Drug Saf 24:119–147.
   PubMed Web of Science ®Google Scholar
• Thomas, T., Thomas, T.J. (2001). Polyamines in cell growth and cell death: molecular mechanisms and therapeutic applications. Cell Mol Life Sci 58:244–258.
   PubMed Web of Science ®Google Scholar
• Thompson, C.M., Capdevila, J.H., Strobel, H.W. (2000). Recombinant cytochrome P450 2D18 metabolism of dopamine and arachidonic acid. J Pharmacol Exp Ther 294:1120–1130.
   PubMed Web of Science ®Google Scholar
• Timsit, Y.E., Negishi, M. (2007). CAR and PXR: the xenobiotic-sensing receptors. Steroids 72:231–246.
   PubMed Web of Science ®Google Scholar
• Tipton, K.F., Boyce, S., O’Sullivan, J., Davey, G.P., Healy, J. (2004). Monoamine oxidases: certainties and uncertainties. Curr Med Chem 11:1965–1982.
   PubMed Web of Science ®Google Scholar
• Tolonen, A., Turpeinen, M., Pelkonen, O. (in press). Liquid chromatography-mass spectrometry in in vitro drug metabolite screening. Drug Discov Today
   PubMed Web of Science ®Google Scholar
• Toninello, A., Pietrangeli, P., De Marchi, U., Salvi, M., Mondovi, B. (2006). Amine oxidases in apoptosis and cancer. Biochim. Biophys Acta 1765:1–13.
   PubMed Web of Science ®Google Scholar
• Trackman, P.C., Kagan, H.M. (1979). Nonpeptidyl amine inhibitors are substrates of lysyl oxidase. J Biol Chem 254:7831–7836.
   PubMed Web of Science ®Google Scholar
• Tsuruoka, S., Ioka, T., Wakaumi, M., Sakamoto, K., Ookami, H., Fujimura, A. (2006). Severe arrhythmia as a result of the interaction of cetirizine and pilsicainide in a patient with renal insufficiency: first case presentation showing competition for excretion via renal multidrug resistance protein 1 and organic cation transporter 2. Clin Pharmacol Ther 79:389–396. Erratum in: Clin Pharmacol Ther 80:645.
   PubMed Web of Science ®Google Scholar
• Tunc, T., Oter, S., Güven, A., Topal, T., Kul, M., Korkmaz, A., et al. (2008). Protective effect of sulfhydryl-containing antioxidants against ischemia/reperfusion injury of prepubertal rat intestine. J Gastroenterol Hepatol Dec 1. [Epub ahead of print]
   Web of Science ®Google Scholar
• Ucar, G., Topaloglu, E., Burak Kandilci, H., Gumusel, B. (2005). Elevated semicarbazide-sensitive amine oxidase (SSAO) activity in lung with ischemia-reperfusion injury: protective effect of ischemic preconditioning plus SSAO inhibition. Life Sci 78: 421–427.
   PubMed Web of Science ®Google Scholar
• Uemura, T., Yerushalmi, H.F., Tsaprailis, G., Stringer, D.E., Pastorian, K.E., Hawel, L. (2008) Identification and characterization of a diamine exporter in colon epithelial cells. J Biol Chem 283:26428–26435.
   PubMed Web of Science ®Google Scholar
• Ulwelling, W. (1985). “Pseudo-allergy”: treatment with an MAO inhibitor. Psychosomatics 26:535–536.
   PubMed Web of Science ®Google Scholar
• Usmani, O.S., Ito, K., Maneechotesuwan, K., Ito, M., Johnson, M., Barnes, P.J., et al. (2005). Glucocorticoid receptor nuclear translocation in airway cells after inhaled combination therapy. Am J Respir Crit Care Med 172:704–712.
   PubMed Web of Science ®Google Scholar
• van Berkel, W.J., Kamerbeek, N.M., Fraaije, M.W. (2006). Flavoprotein mono-oxygenases, a diverse class of oxidative biocatalysts. J Biotechnol 124:670–689.
   PubMed Web of Science ®Google Scholar
• van den Berg, G.A., Kingma, A.W., Elzinga, H., Muskiet, F.A. (1986). Determination of N-(3-acetamidopropyl)pyrrolidin-2-one, a metabolite of spermidine, in urine by isotope dilution mass fragmentography. J Chromatogr 383:251–258.
   PubMed Web of Science ®Google Scholar
• van den Brekel, A.M., Harrington, L. (1994). Toxic effects of theophylline caused by fluvoxamine. Can Med Assoc J 151:1289–1290.
   PubMed Web of Science ®Google Scholar
• Van Hecken, A., Depré, M., Verbesselt, R., Wynants, K., De Lepeleire, I., Arnout, J., et al. (1999). Effect of montelukast on the pharmacokinetics and pharmacodynamics of warfarin in healthy volunteers. J Clin Pharmacol 39:495–500.
   PubMed Web of Science ®Google Scholar
• Varis, T., Kaukonen, K.M., Kivistö, K.T., Neuvonen, P.J. (1998). Plasma concentrations and effects of oral methylprednisolone are considerably increased by itraconazole. Clin Pharmacol Ther 64:363–368.
   PubMed Web of Science ®Google Scholar
• Varis, T., Kivistö, K.T., Backman, J.T., Neuvonen, P.J. (2000). The cytochrome P450 3A4 inhibitor itraconazole markedly increases the plasma concentrations of dexamethasone and enhances its adrenal-suppressant effect. Clin Pharmacol Ther 68:487–494.
   PubMed Web of Science ®Google Scholar
• Vermeir, M., Annaert, P., Mamidi, R.N., Roymans, D., Meuldermans, W., Mannens, G. (2005). Cell-based models to study hepatic drug metabolism and enzyme induction in humans. Expert Opin Drug Metab Toxicol 1:75–90.
   PubMedGoogle Scholar
• Vizcaino, S., Caballero, M.J., Carrillo, J.A., Benitez, J. (2003). Effects of grapefruit juice on ebastine metabolism. Methods and findings in experimental and clinical pharmacology. 25 (Suppl A):170.
   Google Scholar
• von Richter, O., Lahu, G., Huennemeyer, A., Herzog, R., Zech, K., Hermann, R. (2007). Effect of fluvoxamine on the pharmacokinetics of roflumilast and roflumilast N-oxide. Clin Pharmacokinet 46:613–622.
   PubMed Web of Science ®Google Scholar
• Vujcic, S., Diegelman, P., Bacchi, C.J., Kramer, D.L., Porter, C.W. (2002). Identification and characterization of a novel flavin- containing spermine oxidase of mammalian cell origin. Biochem J 367:665–675.
   PubMed Web of Science ®Google Scholar
• Wallace, H.M., Fraser, A.V., Hughes, A. (2003). A perspective of polyamine metabolism. Biochem J 376:1–14.
   PubMed Web of Science ®Google Scholar
• Walsky, R.L., Boldt, S.E. (2008). In vitro cytochrome P450 inhibition and induction. Curr Drug Metab 9:928–939.
   PubMed Web of Science ®Google Scholar
• Walsky, R.L., Obach, R.S., Gaman, E.A., Gleeson, J.P., Proctor, W.R. (2005). Selective inhibition of human cytochrome P4502C8 by montelukast. Drug Metab Dispos 33:413–418.
   PubMed Web of Science ®Google Scholar
• Walubo, A., Barr, S., Abraham, A.M., Coetsee, C. (2004). The role of cytochrome-P450 inhibitors in the prevention of hepatotoxicity after paracetamol overdose in rats. Hum Exp Toxicol 23:49–54.
   PubMed Web of Science ®Google Scholar
• Wang, E.J., Casciano, C.N., Clement, R.P., Johnson, W.W. (2001). Evaluation of the interaction of loratadine and desloratadine with P-glycoprotein. Drug Metab Dispos 29:1080–1083.
   PubMed Web of Science ®Google Scholar
• Wang, Y., Casero, R.A. (2006). Mammalian polyamine catabolism: a therapeutic target, a pathological problem, or both? J Biochem 139:17–25.
   PubMed Web of Science ®Google Scholar
• Wang, Z., Hamman, M.A., Huang, S-M., Lesko, L.J., Hall, S.D. (2002). Effect of St John’s wort on the pharmacokinetics of fexofenadine. Clin Pharmacol Ther 71:414–420.
   PubMed Web of Science ®Google Scholar
• Wantke, F., Hemmer, W., Haglmuller, T., Gotz, M., Jarish, R. (1996). Histamine in wine. Bronchoconstriction after a double-blind, placebo-controlled red wine provocation test. Int Arch Allergy Immunol 110:397–400.
   PubMed Web of Science ®Google Scholar
• Wantke, F., Gotz, M., Jarisch, R. (1994). The red wine provocation test: intolerance to histamine as a model of food intolerance. Allergy Proc 15:27–32.
   PubMedGoogle Scholar
• Watanabe, T., Taguchi, Y., Maeyama, K., Wada, H. (1991). Formation of histamine: histidine decarboxylase. In: Uvnäs, B. (Ed.), Histamine and Histamine Antagonists (pp. 145–163 ). Berlin, Germany: Springer-Verlag.
   Google Scholar
• Weaver, R., Graham, K.S., Beattie, I.G., Riley, R.J. (2003). Cytochrome P450 inhibition using recombinant proteins and mass spectrometry/multiple reaction monitoring technology in a cassette incubation. Drug Metab Dispos 31:955–966.
   PubMed Web of Science ®Google Scholar
• Weber, W.W. (1997). Pharmacogenetics. New York/Oxford: Oxford University Press.
   Google Scholar
• Westerink, W.M., Schoonen, W.G. (2007). Cytochrome P450 enzyme levels in HepG2 cells and cryopreserved primary human hepatocytes and their induction in HepG2 cells. Toxicol In Vitro 21:1581–1591.
   PubMed Web of Science ®Google Scholar
• Whomsley, R., Strolin Benedetti, M. (2005). Development of new H1 antihistamines: the importance of pharmacokinetics in the evaluation of safe and therapeutically effective agents. Curr Med Chem Anti-inflamm Antiallergy Agents 4:451–464.
   Google Scholar
• Whomsley, R., Strolin-Benedetti, M., Baltes, E. (2006). Comment on severe arrhythmia as a result of the interaction of cetirizine and pilsicainide in a patient with renal insufficiency. Clin Pharmacol Ther 80:715–716
   PubMed Web of Science ®Google Scholar
• Wienkers, L.C., Heath, T.J. (2005). Predicting in vivo drug interactions from in vitro drug discovery data. Nat Rev Drug Discov 4:825–433.
   PubMed Web of Science ®Google Scholar
• Wilson, F.E. (1981). Acute respiratory failure secondary to polymyxin-B inhalation. Chest 79:237–239.
   PubMed Web of Science ®Google Scholar
• Wood, P.L., Khan, M.A., Moskal, J.R., Todd, K.G., Tanay, V.A., Baker, G. (2007). The concept of “aldehyde load” in neurodegenerative mechanisms: cytotoxicity of the polyamine degradation products hydrogen peroxide, acrolein, 3-aminopropanal, 3- acetamidopropanal, and 4-aminobutanal in a retinal ganglion cell line. Brain Res 1145:150–156.
   PubMed Web of Science ®Google Scholar
• Worland, P.J., Ilett, K.F. (1983). Intestinal contribution to the presystemic elimination of beta-phenethylamine in the rat. J Pharm Pharmacol 35:636–640.
   PubMed Web of Science ®Google Scholar
• Wütrich, B. (1988). [Acetylsalicylic acid pseudoallergy: an anomaly of thrombocyte function?]. Hautarzt 39:631–634.
   PubMed Web of Science ®Google Scholar
• Xu, R.X., Lambert, M.H., Wisely, B.B., Warren, E.N., Weinert, E.E., Waitt, G.M., et al. (2004). A structural basis for constitutive activity in the human CAR/RXRalpha heterodimer. Mol Cell 16:919–928.
   PubMed Web of Science ®Google Scholar
• Yao, C., Kunze, K.L., Kharasch, E.D., Wang, Y., Trager, W.F., Ragueneau, I., et al. (2001). Fluvoxamine-theophylline interaction: gap between in vitro and in vivo inhibition constants toward cytochrome P4501A2. Clin Pharmacol Ther 70:415–424.
   PubMed Web of Science ®Google Scholar
• Yap, Y.G., Camm, A.J. (1999). Arrhythmogenic mechanisms of nonsedating antihistamines. Clin Exp Allergy 29(Suppl 3):174–181.
   PubMedGoogle Scholar
• Yasui-Furukori, N., Uno, T., Sugawara, K., Tateishi, T. (2005). Different effects of three transporting inhibitors, verapamil, cimetidine, and probenecid, on fexofenadine pharmacokinetics. Clin Pharmacol Ther 77:17–23.
   PubMed Web of Science ®Google Scholar
• Yatsunami, K., Ohtsu, H., Tsuchikawa, M., Higuchi, T., Ishibashi, K., Shida, A., et, al. (1994). Structure of the L-histidine decarboxylase gene. J Biol Chem 269:1554–1559.
   PubMed Web of Science ®Google Scholar
• Yu, A.M., Granvil, C.P., Haining, R.L., Krausz, K.W., Corchero, J., Küpfer, A., et al. (2003). The relative contribution of monoamine oxidase and cytochrome P450 isozymes to the metabolic deamination of the trace amine tryptamine. J Pharmacol Exp Ther 304:539–546.
   PubMed Web of Science ®Google Scholar
• Yu, Z., Li, W., Hillman, J., Brunk, U.T. (2004). Human neuroblastoma (SH-SY5Y) cells are highly sensitive to the lysosomotropic aldehyde 3-aminopropanal. Brain Res 1016:163–169.
   PubMed Web of Science ®Google Scholar
• Yueh, M.F., Kawahara, M., Raucy, J. (2005). High-volume bioassays to assess CYP3A4-mediated drug interactions: induction and inhibition in a single cell line. Drug Metab Dispos 33:38–48.
   PubMed Web of Science ®Google Scholar
• Zangar, R.C., Davydov, D.R., Verma, S. (2004). Mechanisms that regulate production of reactive oxygen species by cytochrome P450. Toxicol Appl Pharmacol 199:316–331.
   PubMed Web of Science ®Google Scholar
• Zhang, F., Xiong, D.H., Wang, W., Shen, H., Xiao, P., Yang, F., et al. (2006). HDC gene polymorphisms are associated with age at natural menopause in Caucasian women. Biochem Biophys Res Commun 348:1378–1382.
   PubMed Web of Science ®Google Scholar
• Zhang, Z.Y., Wong, Y.N. (2005). Enzyme kinetics for clinically relevant CYP inhibition. Curr Drug Metab 6:241–257.
   PubMed Web of Science ®Google Scholar
• Zhou, S., Yung Chan, S., Cher Goh, B., Chan, E., Duan, W., Huang, M., et al. (2005). Mechanism-based inhibition of cytochrome P450 3A4 by therapeutic drugs. Clin Pharmacokinet 44:279–304.
   PubMed Web of Science ®Google Scholar
• Zhu, Z., Kim, S., Chen, T., Lin, J.H., Bell, A., Bryson, J., et al. (2004). Correlation of high-throughput pregnane X receptor (PXR) transactivation and binding assays. J Biomol Screen 9:533–540.
   PubMed Web of Science ®Google Scholar
• Zimatkin, S.M., Anichtchik, O.V. (1999). Alcohol-histamine interactions. Alcohol 34:141–147.
   Web of Science ®Google Scholar